SPIIK ANN-KRISTIN,LOFBERG ROBERT,BANDHOLTZ LISA CHARLOTTA,VON STEIN OLIVER,ZARGARI AREZOU,Spiik Ann-Kristin,Lofberg Robert,Bandholtz Lisa Charlotta,Von Stein Oliver,Zargari Arezou
申请号：
SI200631691
公开号：
SI2179737T1
申请日:
2006.06.30
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention makes it possible to enhance steroid efficacy in a steroid refractory patient afflicted with an inflammatory condition not responding or responding poorly or inadequately to anti-inflammatory treatment, by administering an effective to said patient amount of an oligonucleotide comprising the sequence TTCGT and having a total length of up to 100 nucleotides. The invention also encompasses the use of said oligonucleotide for the manufacture of pharmaceuticals.
